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-Nucleoside triphosphates (NTP) are present in the liquid
covering airway surfaces and mediate important physiologic
events through their interaction with P2-nucleotide receptors.




 receptors, for example, stimulates
ciliary beat frequency, chloride/liquid secretion, and goblet
cell degranulation. We, therefore, have studied the metabolic
pathways that regulate the concentration of nucleotides on
airway surfaces. Stimulation of submucosal gland secretion in





-adenosine triphosphate (ATP) in nasal lavage samples
 





phatase (NTPase). In this study, gland secretions were further
studied and found to also contain adenylate kinase (AK) and
nucleoside diphosphokinase (NDPK) activities. Ecto-AK and
ecto-NDPK activities were also detected in well-differentiated
cultures of superficial nasal epithelia, which reflected a combi-
nation of cell-associated and released (into culture media) AK
and NDPK activities. This study demonstrates that “ecto-kinases”




) emanate from different enzyme fami-




) are expressed at super-





may be important regulators of nucleotide concentrations on
airway surfaces.
 
Extracellular P2X and P2Y nucleotide receptors are widely
expressed throughout the body and mediate a wide array




 subtype appears to be
the dominant apical membrane nucleotide receptor in the
airway epithelia of the lung (1). This G-protein–coupled
receptor activates phospholipase C and increases intracel-









-triphosphate (UTP) (2, 3).





ceptor activation in airway epithelia include chloride se-
cretion (4), acceleration of ciliary beat frequency (5), and
induction of mucus secretion by goblet cells (6). The net
effect of these cellular events on airways physiology is ac-





 receptor system has received attention as an endoge-
nous regulator of mucociliary clearance and as a potential
therapeutic target for diseases characterized by poor mu-
cociliary clearance, such as cystic fibrosis (CF). In addi-
tion, the P2X family of receptors may modulate chloride
secretion and ciliary beat frequency and has been pro-






 receptor is indeed involved in the endoge-





-nucleotide levels is likely an important
physiologic process that will reflect the balance between
nucleotide release and metabolism. In a recent study, we




 receptor agonist ATP was de-
tectable in human nasal airway surface liquid (ASL) under
basal conditions at a physiologically relevant concentra-
tion. The superficial epithelium exhibited the capacity to





-nucleoside triphosphate (NTP) lev-
els via cell surface nucleotidases. Interestingly, when
studying the impact of submucosal gland (SMG) secre-





triphosphatase (NTPase) activity was observed in nasal la-
vages enriched with gland secretions (10).
In the present study, we have investigated the profile of
nucleotide-metabolizing enzymes present in both human
SMG secretions and on superficial epithelial surfaces. In
contrast to traditional paradigms of extracellular nucle-
otide metabolism that focus on dephosphorylation of nu-
cleotides, our data suggest that adenylate kinase (AK) and
nucleoside diphosphokinase (NDPK) play a role in the in-




















 1.7 yr) subjects without visible
nasal inflammation or recent nasal symptoms after obtaining in-
formed consent in accordance with the University of North Caro-
lina Human Rights Committee.
 
Collection of Nasal Submucosal Gland Secretions
 
To study enzyme activities in SMG secretions, a baseline nasal la-
vage was performed by delivering a total of 2 ml of 0.9% saline to





The lavage was recovered by expelling the liquid from the nose
into a sterile specimen cup after every five actuations. To obtain
a lavage enriched with SMG secretions, the same nostril was
dosed with methacholine via nebulizer (30 mg/dose; 100 mg/ml in
0.9% NaCl), followed two minutes later by a lavage as described
above. To test the specificity of methacholine-induced effects,
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adenylate kinase, AK; airway surface liquid, ASL; adeno-
sine triphosphate, ATP; cystic fibrosis, CF; epithelial growth factor, EGF;





























g/actuation), an acetylcholine receptor antagonist,
followed 15 min later by dosing with methacholine (30 mg). Two
minutes after methacholine administration, the nostril was la-
vaged as described above. The volume of each lavage return was









C; 30 min) with
intermittent vortexing to aid the dissolution of mucinous secre-









move cells and undissolved particulate matter.
 
Enzyme Assays in Nasal Lavage Samples
 





C. Reactions were started with the addition of substrate and
stopped with 0.5 ml of cold 5% trichloroacetic acid (TCA). Inhib-
itors were added 15 min before the start of the reaction. TCA was
extracted from the samples using 8 vol of ethyl ether. Initial rates

























































H]ATP) adenylate kinase reac-
tions were studied in lavage fluids using high-performance liquid














C. Aliquots were assayed at multiple




 0, 2, 5, and 10 min) to ensure that initial rates of










activity was observed in nasal lavage samples after inhibiting AK









no significant AMP hydrolysis was observed over comparable




H]UDP as an enzyme substrate was




A (1mM), a spe-













H]ADP (0.1 mM) was assessed with HPLC and quantitated as an




A (1 mM) was included in these re-









 0, 0.5, 1, 2, 5, and 15 min) were collected to measure the initial
rate of reaction in nasal lavages performed after designated treat-

















Well-differentiated primary cultures of the superficial nasal epi-
thelia lining were grown as previously described (12). In brief,
primary nasal epithelial cells were harvested from resected surgi-
cal specimens by protease digestion, plated on porous Transwell





Costar, Aston, MA) and grown under air–liquid interface condi-
tions. The culture medium contained a 50:50 mixture of LHC Basal
(Biofluids, Inc., Rockville, MD) and Dulbecco’s modified Eagle’s









g/ml hydrocortisone, 0.5 ng/ml epithelial growth factor




















M ethanolamine, 50 nM retinoic
acid, 0.5 mg/ml bovine serum albumin, 0.8% bovine pituitary ex-
tract, trace elements (1X; Biofluids Inc.), Stock 4 (1X; Biofluids,









streptomycin. Enzyme assays were performed after 4 wk of con-
fluence. Under these conditions cultures were composed mainly




 90%) and exhibited a transepithelial electrical










Enzyme Assays on Cell Cultures
 
The apical surface of primary cultures of human nasal epithelial








































5.2 glucose, and 25 HEPES [pH 7.4]), and preincubated with KBR













AK and NDPK activity on the mucosal surface was then measured.




























hibit AK activity. All reactions were initiated by the addition of





tubes containing 0.3 ml ice-cold water. The samples were boiled
for 3 min, filtered, and analyzed by HPLC.
 
Cell Culture Enzyme Release Assays
 
Experiments were conducted to investigate whether nasal epithe-
lial cells released ecto-enzymes into the mucosal bath. Cell sur-














medium was collected at various time points and assayed for AK




Nucleotides were separated by HPLC via a Hypersil SAX col-
umn (Bodman, Aston, PA) using a two solvent system consisting

























, pH 3.7). A linear gradient was developed from 100%
buffer A to 80% buffer B over the first 13 min, followed by an ad-
ditional 7 min of 100% buffer A. Absorbance at 264 nm was
monitored with an SPD10A UV detector (Shimadzu; Columbia,
MD), and radioactivity was measured online with a Flo-One de-




All NTPases, including radiolabeled ATP and UTP, were ob-
tained from Amersham Pharmacia (Piscataway, NJ). Tritium la-





H]NTP precursor by incubating the appropriate substrate with
hexokinase (Roche Molecular Biochemicals; Indianapolis, IN)




C, followed by heat inactiva-





H]-nucleoside diphosphate (NDP) was con-




 nasal studies, methacholine was
purchased from Amend Drug and Chemical (Irvington, NJ), and
ipratropium bromide from Boehringer Ingelheim (Ridgefield, CT).






























-Nucleoside Triphosphate and Diphosphate Metabolism 
in Gland Secretions
 
We have previously shown that the concentration of ATP
in nasal lavages obtained after stimulating SMG secretion
is markedly reduced due to the presence of a secreted
NTPase (10). To further characterize the metabolic fate of









H]UTP were added to lavages enriched with SMG secre-





then AMP were formed, with little adenosine formation,
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H]UTP led mainly to









tion. The different rates of AMP and UMP formation from
their respective NTPs, despite similar disappearance rates of
ATP and UTP, suggested that SMG secretions might contain
a complex mixture of enzymes, rather than a single enzyme.
 
Adenylate Kinase Activity in Nasal Submucosal
Gland Secretions
 












added as starting substrates. As predicted from the patterns
of ATP and UTP metabolism (Figure 1), the metabolism of
[3H]ADP occurred much more rapidly than that of [3H]UDP
(54.7  2.3% versus 6.6  3.6% metabolized over 15 min, re-
spectively) (Figure 2). Interestingly, the disappearance of
[3H]ADP was associated not only with [3H]AMP formation,
but also with the appearance of a second peak that ran pre-
cisely at the location of [3H]ATP. Based on this observation,
we hypothesized that AK was responsible for ADP metabo-
lism in nasal lavage samples.
To test this notion further, we preincubated lavage so-
lutions with diadenosine pentaphosphate (AP5A), a com-
petitive inhibitor of adenylate kinase (11), before examin-
ing ADP metabolism. AP5A itself was not metabolized (data
not shown), but did completely block the metabolism of
[3H]ADP (Figure 2C). [3H]UDP metabolism was notably
slower than that of [3H]ADP and was also inhibited by
AP5A (Figures 2E and 2F).
As another test for the presence of AK activity in SMG
secretions, we added [	33P]ATP and either AMP or UMP
to lavage solutions. The formation of [33P]ADP from
[	33P]ATP and AMP did indeed occur in an AP5A sensitive
manner (Figures 3A–3C), confirming the presence of a
NMPK activity. The formation of [33P]UDP from [	33P]ATP
and UMP was very slow (Figure 3D) and blocked by
AP5A (Figure 3E). The transphosphorylation of AMP by
ATP (Figure 3B), with poor UMP utilization (Figure 3D),
is consistent with the substrate specificity of most AK iso-
forms (AK1, AK2, AK4, and AK5) and rules out other
nucleoside monophosphate kinase family members (13).
Using [3H]ADP as the starting substrate, we quantified
AK activity in SMG secretions (Figure 3F). With saturat-
ing substrate concentrations and short time intervals, the
production of [3H]AMP directly reflected AK activity be-
cause ADP metabolism was entirely AP5A sensitive and
no AMP degradation occurred under these conditions
(Figure 2). Note that the formation of ATP from ADP did
not quantitatively reflect AK activity due to the concomi-
tant presence of an NTPase (Figure 1). The AK activity in
lavages enriched with SMG secretions was  9-fold higher
than in control lavages (P  0.001). Pretreatment with ip-
ratropium markedly reduced the methacholine-induced
increase in AK activity, (P  0.01).
Nucleoside Diphosphokinase Activity in Nasal Submucosic 
Gland Secretions
NDPK, which catalyzes the transfer of the 	-phosphate
group from a NTP donor molecule to a NDP acceptor, is
generally known as an intracellular enzyme responsible
for balancing the intracellular pool of available NTPs (14).
Recent work by Lazarowski and colleagues, however, dem-
onstrated that an NDPK activity is present on the apical
surface of a variety of cell lines, including a human bron-
chial epithelial cell line, and is able to interconvert NTPs
in the extracellular milieu (15, 16). We hypothesized that
SMG secretions might also contain this enzyme. We there-
fore performed NDPK assays on control lavages (no
methacholine treatment), after methacholine treatment,
and after ipratropium bromide plus methacholine.
NDPK activity was present in nasal lavages, as demon-
strated by the transfer of the terminal phosphate group
from [33P]	ATP to UDP, forming [33P]	UTP, and by the
formation of [3H]ATP from [3H]ADP 
 ATP (in the pres-
ence of AP5A, to eliminate competition with AK) (Figures
4A–4D). Because an NTPase is also present in SMG secre-
tions, the measured formation of labeled NTP underesti-
mates the true NDPK activity present in these lavage solu-
tions. Despite this limitation, [3H]ADP was converted to
[3H]ATP in the presence of unlabeled ATP and excess
AP5A at 10.7 nmol/min/ml in lavages enriched with SMG
secretions (Figure 4E). This represents a 4-fold increase in
comparison with control lavages (P  0.001). Once again,
pretreatment with ipratropium bromide inhibited the sub-
sequent increase in NDPK activity in lavages after metha-
choline treatment (P  0.02).
Figure 1. The pattern of NTP metabolism in SMG secretions.
(A) [3H]ATP or (B) [3H]UTP (100 M) were added to nasal la-
vages samples collected after stimulating nasal submucosal gland
secretion with methacholine. The formation of metabolic prod-
ucts was monitored with HPLC over time (closed squares, NTP;
open circles, NDP; closed triangles, NMP; open triangles, adeno-
sine/uridine).
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AK and NDPK Activity on Superficial Airway
Epithelial Surfaces
The presence of AK and NDPK activity in SMG secretions
suggested that these enzymes might play a role in superficial
airway epithelial extracellular nucleotide metabolism. We
therefore used well-differentiated airway epithelial cultures
to determine whether AK and NDPK were also cell surface-
associated ecto-nucleotidases. Using AP5A as a probe for
AK activity, [3H]ADP conversion to [3H]AMP was inhib-
ited by 59% (0.51  0.05 versus 0.21  0.03 nmol/min/cm2),
the difference (0.30 nmol/min/cm2) reflecting AK activity. To
more directly demonstrate AK activity, the formation of
[33P]ADP from AMP and [	33P]ATP was further quantitated
on cell surfaces. Although specific for the AK reaction, this
assay likely underestimates AK activity due to the concomi-
tant presence of AP5A-insensitive ADP metabolism on cell
surfaces. Despite this limitation, significant AK activity was
indeed detected at the apical surface of nasal surface epi-
thelial cells (Figure 5A).
To test whether the observed AK activity was strictly
cell-associated or the result of released/shed enzymes, the
formation of [33P]ADP from [	33P]ATP and AMP was
Figure 2. NDP Metabolism and
in SMG Secretions. (A) [3H]ADP
or (D) [3H]UDP (0.1 mM) were
added to nasal lavages enriched
with SMG secretions at t  0 min.
(B) The conversion of [3H]ADP
to [3H]ATP and [3H]AMP at t 
15 min is shown, whereas (E)
minimal [3H]UDP metabolism
occurred over this time interval.
The AK inhibitor AP5A (500 M)
blocked the metabolism of (C)
[3H]ADP and (F) [3H]UDP.
Figure 3. AK activity in SMG se-
cretions: ATP 
 AMP ↔ 2 ADP.
The formation of [33P]ADP from
[	33P]ATP (0.1 mM) 
 AMP
(0.1 mM) confirmed the presence
of AK in SMG secretions. (A) At
t  0 min only [	33P]ATP was seen.
(B) At t  30 min, the transfer of
the 	33-phosphate group from ATP
to AMP resulted in the formation
of [33P]ADP. (C) The addition of
AP5A (0.5 mM) to lavages com-
pletely blocked the formation of
[33P]ADP; t  30 min. (D) Minimal
[33P]UDP is produced from [	33P]ATP
(0.1 mM) 
 UMP (0.1 mM) at t 
30 min, which was blocked (E) by
the addition of AP5A (0.5 mM).
Note the liberation of free PO43
(B, C, D, and E) as the result of
NTPase activity in SMG secretions.
(F ) AK activity was quantitated in
lavages collected under control con-
ditions (Cont); after stimulating SMG
secretion with methacholine (Meth) (*P  0.001 versus Cont); and with methacholine treatment after ipratropium bromide pretreat-
ment (Ipra 
 Meth) (†P  0.01 versus Meth) using [3H]ADP (0.5 mM) as the starting substrate.
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monitored in parallel experiments using conditioned me-
dia collected from the apical surface of cultures. After a
30-min preincubation in KBR, a majority of the AK activ-
ity was cell-associated, although a significant fraction of
the total activity was contained in the conditioned media
(Figure 5A). With increasing incubation times, condi-
tioned media was found to contain progressively greater
amounts of AK activity (Figure 5B).
NDPK activity was also assayed on the mucosic surface
of well-differentiated airway epithelial cultures using the
[	33P]ATP 
 UDP → ADP 
 [	33P]UTP reaction. Like
AK, a majority of the NDPK activity was cell associated
after a 30-min preincubation in KBR, although significant
activity was also present in conditioned media collected
from the apical compartment (Figure 5A). Once again, the
amount of NDPK activity in conditioned media increased
over time (Figure 5B). Of note, NTPase activity on cells
confounded NDPK activity measurements, causing our
measurements to underestimate total activity.
Discussion
Extracellular nucleotides, via their interaction with airway
P2Y2 receptors, play an important role in regulating ele-
ments of the mucociliary clearance apparatus. The regulation
of extracellular nucleotide concentrations is physiologi-
cally important, therefore, and involves both nucleotide
release and metabolic pathways.
General schemes of extracellular nucleotide metabolism
have included a role for (1) the E-NTPDase family (e.g.,
CD39 and CD39L1–CD39L5) in NTP and NDP hydroly-
sis; (2) the ecto-phosphodiesterase/nucleotide pyrophos-
phatase (PDNP) family for ATP, ADP, and dinucleotide
metabolism; (3) alkaline phosphatase, with the capacity to
dephosphorylate nucleoside 5tri-, di- and monophosphates;
and (4) ecto-5nucleotidase, which hydrolyzes NMP to nu-
cleoside (17). Once fully dephosphorylated, the resulting
nucleosides may be scavenged by nucleoside transporters
(18). In airways, a full characterization of the relevant
ecto-nucleotidases has not been performed. Recent stud-
ies found evidence for an ecto-alkaline phosphodiesterase
activity that was responsible for dinucleotide metabolism
on well-differentiated airway cultures (19), and Lazarowski
and colleagues demonstrated that ecto-NDPK activity is
present on the apical and basolateral surfaces of primary
airway epithelial cultures (20).
The complexity of nucleotide metabolic pathways in
airways is further increased by the fact that ecto-nucleo-
tidases are associated with both the superficial epithelium
and submucosic gland secretions (10). In this study, we
showed that SMG secretions contain robust AK and NDPK
activities, in addition to the previously described NTPase
activity. AK and NDPK activities were also detected on
the apical surface of well-differentiated airway epithelial
cultures. Interestingly, a significant proportion of this ac-
Figure 4. NDPK activity in SMG se-
cretions: XTP 
 YDP ↔ XDP 
 YTP.
NDPK activity in SMG secretions was
demonstrated by adding [	33P]ATP
(0.5 mM) and unlabeled UDP (0.1 mM)
in the presence of AP5A (1 mM) to
block AK activity. (A) At t  0 min,
only the radiolabeled starting reactant
is seen. (B) At t  5 min, the formation
of [	33P]UTP was observed, as well as
the liberation of free PO43 due to the
concomitant presence of NTPase activ-
ity. NDPK activity was further demon-
strated by adding [3H]ADP (0.1 mM) 

ATP (0.05 mM) in the presence of
AP5A (1 mM). (C) At t  0 min only
the radiolabeled starting reactant is
seen. (D) At t  5 min [3H]ATP for-
mation was observed. (E) Using these
reaction conditions, NDPK activity
was quantitated in lavages collected under control conditions (Cont); after stimulating SMG secretion with methacholine (Meth) (*P 
0.001 versus Cont); and with methacholine treatment after ipratropium bromide pretreatment (Ipra 
 Meth) (†P  0.02 versus Meth).
Figure 5. AK and NDPK
activity on human nasal
epithelial cells. (A) To-
tal AK and NDPK ac-
tivities (solid columns)
on airway epithelial sur-
faces were determined,
as well as the propor-
tion of activity that was
released into the api-
cal media (shaded col-
umns), after a 30 min
preincubation in KBR.
(B) The release of AK
(solid columns) and
NDPK (open columns)
activities into the api-
cal culture media over
time was monitored af-
ter washing airway sur-
faces with KBR.
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tivity was released into the culture medium over time, sug-
gesting either shedding of membrane-associated enzymes
or the presence of an enzyme secretory pathway. The com-
monality of enzymes found in SMG secretions and on the
surface of airway epithelial cells suggests that these “ecto-
kinases” (AK and NDPK) might have an important role in
extracellular nucleotide metabolism, which has not previ-
ously been recognized.
Most notable, perhaps, is the finding of ecto-AK activity
in SMG secretions and on airway surfaces. AK catalyzes the
reversible transfer of a phosphate group between ATP and
AMP, forming ADP, and has traditionally been viewed as
an intracellular enzyme responsible for the control of intra-
cellular adenine nucleotide composition. Five mammalian
isoforms have been identified to date (AK1–AK5), which
are encoded by separate genes and include both mitochon-
drial and cytosolic forms. Precedent for a plasma membrane
isoform is scant and comes from reports of ecto-AK activity
in human umbilic vein endothelic cells (HUVEC) (21), syn-
aptosomic brain preparations (22), and an innervated frog
muscle preparation (23). As a consequence, AK is not often
considered when extracellular nucleotide metabolism is
studied. Importantly, its activity can be missed when nucle-
otide metabolism assays rely on the liberation of free phos-
phate and when ATPase and/or ADPase activities are also
present. Utilization of HPLC to assay reaction products,
and AP5A as a specific inhibitor of AK (11), permits detec-
tion of AK when significant activity is present.
Nucleoside diphosphokinase, another enzyme that tradi-
tionally has been viewed as an intracellular regulator of nu-
cleotide pools, was also found to play a role in extracellular
nucleotide metabolism in airways. The notion of an ecto-
NDPK was initially raised by multiple reports of nm-23–
anti-metastasis gene products (24), which encode NDPK iso-
forms expressed at the cell surface (25). Further evidence for
an ecto-NDPK comes from recent reports that demonstrated
NDPK activity on the surface of a variety of cells, including
primary human nasal epithelial cells (20), 16HBE14o hu-
man bronchial epithelial cells (16), and HUVEC cells (21).
Because a single cell type may possess more than one P2-
nucleotide receptor species with different nucleotide agonist
selectivity, it has been speculated that ecto-NDPK may alter
the balance of extracellular nucleotide species, and thereby
effect signaling through P2 receptors (26). For example,
ATP released into the extracellular milieu may donate its
terminal phosphate group to a UDP molecule in the same
compartment, thus forming UTP and allowing activation of
the UTP-selective P2Y4 receptor (16).
Understanding the impact of AK and NDPK on extra-
cellular nucleotide metabolism within the larger framework
of ecto-nucleotidases on airway surfaces is an important,
though complicated, issue. In the context of a complex sys-
tem of enzymes, the role that individual components play
will depend upon several variables, including enzyme Km
and Vmax. The enzyme Vmax, in turn, is proportional to the
abundance of the enzyme and its Kcat. In addition, because
AK and NDPK each utilize two substrate molecules, the
concentration of individual nucleotide substrates in the lo-
cal milieu is an important determinant of activity. Because
the reported Km values ( 100 M) for AK (21, 27) and
NDPK (15) are similar to those of other airway ecto-nucle-
otidases (28), the impact that these enzymes have on extra-
cellular nucleotide metabolism will depend primarily on
the enzyme Vmax and substrate concentrations.
In the experimental systems we have studied (i.e., sur-
face epithelial cells and submucosic gland secretions), the
relative importance of AK and NDPK varies. On surface
epithelial cells, E-NTPases have  10-fold higher activity
(10) than AK and NDPK and so will likely serve as the
major pathway for NTP degradation. With regard to ADP
metabolism, however,  50% of surface epithelial cell
ADP metabolism was inhibited by AP5A, suggesting that
AK significantly contributes to the metabolism of this nu-
cleotide at this site. NDPK, on the other hand, will prima-
rily serve to distribute phosphate groups among available
nucleotide species.
In human nasal lavage samples, however, a very differ-
ent profile of nucleotidase activities was observed. NDPK
and AK activities were much greater than that of the
E-NTPase (10) ( 30-fold and 6-fold, respectively) in na-
sal lavages collected under unstimulated conditions. After
stimulating glandular secretion with methacholine, all three
enzyme activities significantly increased, although NDPK
acitivity continued to dominate (NDPK  AK  NTPase).
In contrast to the pattern seen on superficial epithelial
cells, ADP metabolism was entirely sensitive to AP5A. This
result suggests that AK is essential for ADP metabolism in
SMG secretions and that the secreted E-NTPase strongly
prefers NTP species over NDPs.
The relative importance of secreted versus cell-attached
nucleotidases in NTP metabolism on airway surfaces in
vivo is difficult to assess because the relative contribution
of submucosal glands and superficial epithelia to airway
surface liquid volume/composition is generally unknown
and likely to be extremely variable. In lung regions that
are heavily populated with submucosal glands (proximal
airways), especially under conditions that increase the rate
of SMG secretion (see below), extracellular nucleotide me-
tabolism may be profoundly affected, or even dominated,
by nucleotidases contained in SMG secretions. In these re-
gions, the secreted NTPase will contribute to NTP metab-
olism, whereas AK is expected to prevent the buildup of
ADP when coupled to the actions of this NTPase. The im-
portance of NDPK in these systems relies on its ability to
transfer phosphate groups between different nucleotide
species and thus potentially alter the pattern of nucleotide
receptor activation (15, 16).
The finding that nucleotide-metabolizing enzymes are
secreted from submucosal glands provides new insights
into the regulatory processes that limit airway nucleotide
receptor activation. For example, one may speculate that
gland secretions provide a reserve capacity for nucleotide
metabolism. In the setting of airway inflammation/irri-
tants, where nucleotide levels are expected to be elevated
due to cellular breakdown, stimulated gland secretion may
provide a means to regulate ATP and ADP levels through
the combined actions of the secreted NTPase (10) and
AK. These activities, in turn, may prevent prolonged nu-
cleotide receptor stimulation and/or desensitization. Whether
diseases characterized by pathologic gland hypersecretion,
e.g., chronic bronchitis, have reduced nucleotide levels in
vivo is worth exploring given the potential ramifications of
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reduced ATP levels on mucociliary clearance. The impact
that secreted nucleotidases have on nucleotide-based ther-
apies for lung diseases will also need to be considered.
The finding of secreted nucleotidases in a biologic sys-
tem is not a unique phenomenon. In other tissues with
exocrine glands, such as oviduct (29, 30) and prostate (31,
32), the secretion of an ATPase has previously been ob-
served. In these tissues, enzyme secretion is mediated via
“shedding” of vesicular material (33). In addition, release
of an ATPase from nerve terminals upon electric stimula-
tion has been described (34). It is possible, therefore, that
the secretion of nucleotidases from nasal submucosal
glands may occur either via microvesicular shedding from
epithelial cell surfaces or through a classic exocytotic path-
way. The mechanism underlying the release of surface-
associated nucleotidases in our cultured epithelial prepa-
rations is also unclear. A similar phenomenon, including
the release of both an ATPase and 5-nucleotidase, has
been observed in endothelial cells in response to shear
stress (35). Our data demonstrate for the first time, how-
ever, that nucleotidase secretion can be mediated by re-
ceptor activation. This finding raises the question whether
other tissues that respond to cholinergic stimulation may
release nucleotidases in a similar fashion.
The identification of ecto-NDPK and ecto-AK as poten-
tially important determinants of extracellular nucleotide con-
centrations furthers our knowledge of the regulatory processes
that influence nucleotide-mediated signaling in airways. Future
studies focusing on molecular identification of specific ecto-
nucleotidases/ecto-kinases in airways, the biochemic character-
ization of the integrated system at physiologic substrate con-
centrations, and of cell biologic processes that determine cell
surface enzyme expression and/or secretion should greatly im-
prove our understanding of this complex enzyme system.
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